1b3a: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1b3a.png|left|200px]] | [[Image:1b3a.png|left|200px]] | ||
{{STRUCTURE_1b3a| PDB=1b3a | SCENE= }} | {{STRUCTURE_1b3a| PDB=1b3a | SCENE= }} | ||
===TOTAL CHEMICAL SYNTHESIS AND HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE POTENT ANTI-HIV PROTEIN AOP-RANTES=== | ===TOTAL CHEMICAL SYNTHESIS AND HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE POTENT ANTI-HIV PROTEIN AOP-RANTES=== | ||
{{ABSTRACT_PUBMED_9889151}} | {{ABSTRACT_PUBMED_9889151}} | ||
==About this Structure== | ==About this Structure== | ||
[[1b3a]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1B3A OCA]. | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:009889151</ref><references group="xtra"/> | ||
[[Category: Barlow, P N.]] | [[Category: Barlow, P N.]] | ||
[[Category: Hoover, D.]] | [[Category: Hoover, D.]] | ||
| Line 33: | Line 21: | ||
[[Category: Wilken, J.]] | [[Category: Wilken, J.]] | ||
[[Category: Wlodawer, A.]] | [[Category: Wlodawer, A.]] | ||
[[Category: Anti-hiv protein]] | |||
[[Category: Chemical protein synthesis]] | [[Category: Chemical protein synthesis]] | ||
[[Category: Chemokine]] | [[Category: Chemokine]] | ||
[[Category: Hiv-1]] | [[Category: Hiv-1]] | ||
[[Category: Rante]] | [[Category: Rante]] | ||
Revision as of 11:43, 21 October 2012
TOTAL CHEMICAL SYNTHESIS AND HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE POTENT ANTI-HIV PROTEIN AOP-RANTES
Template:ABSTRACT PUBMED 9889151
About this Structure
1b3a is a 2 chain structure. Full crystallographic information is available from OCA.
Reference
- Wilken J, Hoover D, Thompson DA, Barlow PN, McSparron H, Picard L, Wlodawer A, Lubkowski J, Kent SB. Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES. Chem Biol. 1999 Jan;6(1):43-51. PMID:9889151 doi:10.1016/S1074-5521(99)80019-2
